Status:
COMPLETED
Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin
Lead Sponsor:
Amgen
Collaborating Sponsors:
Medtronic
Conditions:
Parkinson's Disease
Eligibility:
All Genders
35-70 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to determine long-term efficacy of continuous IPu liatermin infusion administered with concomitant standard anti-Parkinsonian therapy.
Eligibility Criteria
Inclusion
- Inclusion Criteria: - Completion of the 20020168 protocol
Exclusion
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2006
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT00111982
Start Date
December 1 2003
End Date
February 1 2006
Last Update
February 26 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.